Manual Therapy on Activation of the Descending Pain Inhibitory System in Patients With Knee Osteoarthritis
NCT ID: NCT04256135
Last Updated: 2020-07-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
28 participants
INTERVENTIONAL
2020-04-30
2020-06-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Methods: Experimental, prospective, parallel and longitudinal double-blind study, in which two groups are performed: group A (AP mobilizations) and group B (Mulligan's mobilizations). Different variables and questionnaires were used: pressure pain threshold, temporal summation, pain modulation, central sensitization inventory, WOMAC, Times Up \& GO, numerical rating scale, Beck, STAI, kinesiophobia, catastrophism, Barthel and mini- cognitive test
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
End-range Mobilization on Knee Osteoarthritis
NCT04270253
The Effect of Mobilization With Movement on Pain and Function Among Patients With Knee Osteoarthritis
NCT02865252
Mobilization With Movement in Patients With Osteoarthritis of the Hip
NCT02390336
Effects Of Maitland's Mobilization At Mid Versus End Range In Knee Osteoarthritis Patients
NCT06751095
Effect of Mulligan'Mobilization With Movement on Pain, Disability and Range of Motion in Patients With Knee Osteoarthritis
NCT01756378
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The pain of knee osteoarthritis is a multifactorial phenomenon in which structural, neurophysiological and psychosocial factors are involved. With regard to neurophysiological factors, it has been found that there are inflammatory mediators within the articular cartilage which alter afferent sensory inputs and cause plastic changes in the nervous system leading to central sensitization (CS).
Sensitization is defined as an increased response to a painful stimulus, accentuating the signal in the central nervous system, either by increasing the pain signal or by decreasing the pain inhibition signals.
On the other hand, magnetic resonance studies have shown that patients with gonarthrosis have a higher degree of vigilance and a lower capacity to disconnect pain, related to the abnormal activity of different areas of the brain such as the prefrontal areas, the cingulate cortex, the insula, the amygdala and the nucleus accumbens.
The therapies that have had more evidence are pharmacological, non-pharmacological, surgical, infiltration, physical therapies, and lifestyle changes. Because most have side effects, physical therapy is often advised.
The investigators found studies using multimodal treatments, which aim to look for synergistic effects to achieve a better outcome. But it has been shown that if these treatments do not include manual therapy they do not cause changes in central sensitization.
The hypothesis of the study is that with AP and Mulligan's mobilizations the investigators can activate the downward chain.
Primary Objective To evaluate the effectiveness of joint mobilization versus Mulligan's treatment on the activation of conditioned pain modulation, temporal summation, and generalized and local mechanical hyperalgesia Secondary objective As secondary objectives, we will evaluate the effect of accessory mobilizations versus Mulligan's treatment on disability, functionality, central awareness characteristics and psychosocial aspects.
METHODOLOGY RESEARCH DESIGN It is an experimental, prospective, parallel and longitudinal double-blind study with elderly patients with knee osteoarthritis.
PARTICIPANTS Selection of participants: elderly participants from a resident of the elderly in Comunidad de Madrid, who are informed of the procedure and asked for informed consent.
SAMPLE SIZE The sample size will be calculated by means of the "Gpower 3.0.18." computer program.
RANDOM Randomization will be done through the GraphaPad software (GraphPad Software, Inc CA 92037 USA). Patients who meet the inclusion criteria and have none of the exclusion criteria will be entered into the study and the sample will be randomized to obtain the two groups, in opaque, sealed envelopes: A and B.
MASKING The double-blind criteria are met, in which the subjects participating in the study will not know the group to which they were assigned, as well as the physiotherapist in charge of collecting the variable data.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental mobilization: Mulligan
Mobilization will be performed while the patient actively performs knee flexion and/or extension depending on the patient's painful or limited movements. Three series of ten repetitions will be performed.
Mulligan mobilization
Mobilization will be performed while the patient actively performs knee flexion and/or extension depending on the patient's painful or limited movements. Three series of ten repetitions will be performed.
Control mobilization: AP Maitland
The joint mobilization, will be carried out in the knee with both hands, with displacement of the tibia from the front to the back of the femur in an oscillatory way without pain, will be carried out in blocks of 2 minutes with rests of 30 seconds with a duration of about 6 minutes.
AP Maitland mobilization
The joint mobilization, will be carried out in the knee with both hands, with displacement of the tibia from the front to the back of the femur in an oscillatory way without pain, will be carried out in blocks of 2 minutes with rests of 30 seconds with a duration of about 6 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mulligan mobilization
Mobilization will be performed while the patient actively performs knee flexion and/or extension depending on the patient's painful or limited movements. Three series of ten repetitions will be performed.
AP Maitland mobilization
The joint mobilization, will be carried out in the knee with both hands, with displacement of the tibia from the front to the back of the femur in an oscillatory way without pain, will be carried out in blocks of 2 minutes with rests of 30 seconds with a duration of about 6 minutes.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Low or no response to pain medication for osteoarthritis knee pain.
Exclusion Criteria
* Infiltration with steroids or local anaesthetics during the year prior to the patient's participation in the study or during follow-up.
* History of previous lower extremity or lumbopelvic surgery.
* Ingestion of substances of abuse that may interfere with treatment.
* Contraindications to perform joint therapy mobilizations.
* Previous diagnosis of myopathy or neuropathy (lumbo-sacral plexus)
* Cognitive deficit manifested in the clinical history (Alzheimer, dementia).
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidad Rey Juan Carlos
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Josue Fernandez Carnero
Associate Profesor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Josué Fernández Carnero, Phd
Role: PRINCIPAL_INVESTIGATOR
Universidad Rey Juan Carlos
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidad Rey Juan Carlos
Alcorcón, Madrid, Spain
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0902201803618
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.